WYE: WYETH Profile

Ticker

Advertisement

Choose a Broker

Dynamic view of the market

Symbol	Value	Change	Percentage Change
DJIA	11,632.38	29.88	0.26%
NASDAQ	2,325.88	21.92	0.95%
S&P 500	1,282.19	5.19	0.41%

WYETH

WYE

Stock price

45.55 0.87 1.95%

as of 04:00 PM EDT on 07/23/2008 in USD (NYSE Delay: 20 mins.)
Extended Hours

45.737 0.187 0.41%

as of 05:00 PM EDT on 07/23/08

Analyst Consensus

Hold
Analyst Consensus

Strong Buy

Buy

Hold

Sell

Strong Sell
- Add to Portfolio
- Add to Alerts
Discuss: WYE

Insightful information about industries, companies, and the people who lead them.

Learn More.

2007 Sales	2007 Sales Growth	2007 Net Income	2007 Employees
$22,399,800,000	10.1%	$4,616,000,000	50,527

Key Executives: WYE

Name	Title	Officer Since
Bernard J. Poussot	CEO	1/26/07
Greg Norden	CFO	-
Lawrence V. Stein	General Counsel	-
Robert R. Ruffolo, Jr., Ph.D.	Senior VP	-
Ulf Wiinberg	Senior VP	-
Joseph M. Mahady	Senior VP	-
John C. Kelly, CPA	Vice President	-
Michael J. Critelli	Director Nominee	-

View All Key Executives

Robert R. Ruffolo Jr., Ph.D, 58, Senior Vice President and President, Wyeth Research, Member of Management, Law/Regulatory Review, Operations and Human Resources and Benefits Committees, Business Experience: November 2000 to June 2002, Executive Vice President, Pharmaceutical Research and Development, Wyeth Research, June 2002 to date, Senior Vice President and President, Wyeth Research. On April 30, 2008, Wyeth announced that Robert R. Ruffolo,... View Full Profile

Robert R. Ruffolo, Jr., Ph.D.

Mr. Poussot is 56 years old and has been a Director since January 2007. Mr. Poussot is our Chief Executive Officer, a position he has held since January 2008, and our President, a position he has held since April 2006. He was our Chief Operating Officer from January 2007 through December 2007 and our Vice Chairman from April 2006 through December 2007. From June 2002 to April 2006, he was Executive Vice President of Wyeth and President, Wyeth... View Full Profile

Bernard J. Poussot

Gregory Norden, 50, Senior Vice President and Chief Financial Officer. Member of Management, Operations, Law/Regulatory Review, Human Resources and Benefits and Retirement Committees. Business Experience: 1996 to 1999, Vice President Finance, Wyeth-Ayerst Pharmaceuticals, January 2000 to October 2000, Senior Vice President/Chief Financial Officer, Wyeth Pharmaceuticals, October 2000 to June 2007, Executive Vice President, Wyeth Pharmaceuticals,... View Full Profile

Greg Norden

Mr. Critelli is 59 years old and has been nominated as a Director by our Board for election at our 2008 Annual Meeting of Stockholders. Mr. Critelli has been Executive Chairman of Pitney Bowes Inc., a provider of mailstream solutions, since May 2007. Prior to that, Mr. Critelli was the Chairman and Chief Executive Officer of Pitney Bowes Inc. from January 1997 through May 2007. Mr. Critelli is also a Director of Eaton Corporation.... View Full Profile

Michael J. Critelli

Mr. Critelli is 59 years old and has been nominated as a Director by our Board for election at our 2008 Annual Meeting of Stockholders. Mr. Critelli has been Executive Chairman of Pitney Bowes Inc., a provider of mailstream solutions, since May 2007. Prior to that, Mr. Critelli was the Chairman and Chief Executive Officer of Pitney Bowes Inc. from January 1997 through May 2007. Mr. Critelli is also a Director of Eaton Corporation.... View Full Profile

Walter V. Shipley

Mr. Amen is 58 years old and has been a Director since 2007. Since July 2006, he has been the Chairman and Chief Executive Officer of International Flavors & Fragrances Inc., a leading creator and manufacturer of flavors and fragrances used in a wide variety of consumer products and packaged goods. He was previously with International Paper Company, a paper and packaging company, where he was President from 2003 until 2006 and previously... View Full Profile

Robert M. Amen

Dr. Langer is 59 years old and has been a Director since January 2004. He was named an Institute Professor at Massachusetts Institute of Technology in 2006 and has been on the faculty of Massachusetts Institute of Technology since 1977. He is also a Director of Alseres Pharmaceuticals, Inc., Echo Therapeutics, Inc. and Momenta Pharmaceuticals, Inc.... View Full Profile

Dr. Robert S. Langer, Sc.D.

Ulf Wiinberg, 49, Senior Vice President and President, Wyeth Pharmaceuticals - Europe/Middle East/Africa/Canada and BioPharma. Member of Management and Operations Committees. Business Experience: May 1997 to February 2002, Managing Director of the United Kingdom subsidiary of Wyeth Pharmaceuticals, February 2002 to June 2005, President, Wyeth Consumer Healthcare, June 2005 to January 2007, Senior Vice President and President, Wyeth... View Full Profile

Ulf Wiinberg

Mr. McGuire is 51 years old and has been a Director since October 2006. Mr. McGuire has been Co-Head, Global Investment Banking at Citi since 2005. Prior to that, Mr. McGuire was the Global Co-Head of Mergers & Acquisitions at Morgan Stanley from 2003 to May 2005; a Managing Director at Morgan Stanley from 2000 to 2003; a Managing Director in the Mergers and Acquisitions Group of Merrill Lynch & Co., Inc. from 1994 to 2000; and one of the... View Full Profile

Raymond J. McGuire

Dr. Fergusson is 63 years old and has been a Director since January 2005. She is a Professor at Vassar College and is President Emeritus of the College, a position she held from 1986 to July 2006. She is also a Director of HSBC Bank USA and Mattel, Inc. and is President of the Board of Overseers of Harvard University.... View Full Profile

Dr. Frances D. Fergusson, Ph.D.

Mr. Rogers is 63 years old and has been a Director since October 2005. He is former Vice Chairman of General Electric Company, a position he held from 2001 through 2003. Prior to that, Mr. Rogers held various executive positions during his long tenure at General Electric. He is also a Director of Rohm and Haas Company and W.W. Grainger, Inc.... View Full Profile

Gary L. Rogers

Mr. Ganzi is 61 years old and has been a Director since December 2005. Mr. Ganzi has been the President and Chief Executive Officer since 2002 and a Director since 1990 of The Hearst Corporation, a diversified communications company. He is also a Director and non-executive Chairman of Hearst Argyle Television, Inc. (majority owned by The Hearst Corporation) and a Director of Gentiva Health Services, Inc.... View Full Profile

Victor F. Ganzi

Mr. Mascotte is 68 years old and has been a Director since 1995. He is the retired President and Chief Executive Officer of Blue Cross and Blue Shield of Kansas City, Inc., a position he held from 1997 through 2001. He is also the former Chairman of Johnson & Higgins of Missouri, Inc. and former Chairman and Chief Executive Officer of The Continental Corporation.... View Full Profile

John P. Mascotte

Professor Feerick is 71 years old and has been a Director since 1987. Since 2007, he has chaired the New York State Commission on Public Integrity. Since 2002, he has been a full-time Professor of Law at Fordham University School of Law and is the former Dean of Fordham University School of Law, a position he held from 1982 until 2002. He is also a Director of Sentinel Group Funds, Inc.... View Full Profile

Professer John D. Feerick

Mr. Torell is 68 years old and has been a Director since 1982. He is Partner at Core Capital Group, LLC, a position he has held since 2000. He is also Chairman of Indecomm Global Services Corporation and International Executive Services Corps. He is the former President of Manufacturers Hanover Corporation and Manufacturers Hanover Trust Company, former Chairman of the Board, President and Chief Executive Officer of CalFed Inc. and former... View Full Profile

John R. Torell, III

Joseph M. Mahady, 54, Senior Vice President and President, Wyeth Pharmaceuticals. Member of Management, Operations, Law/Regulatory Review and Human Resources and Benefits Committees. Business Experience: September 1997 to June 2002, President, Wyeth Pharmaceuticals - North America, June 2002 to June 2003, Senior Vice President and President - North America, Wyeth Pharmaceuticals, June 2003 to June 2005, Senior Vice President and President - North... View Full Profile

Joseph M. Mahady

Lawrence V. Stein, 58, Senior Vice President and General Counsel, Member of Management, Operations, Law/Regulatory Review, Operations, Human Resources and Benefits and Retirement Committees, July 2000 to June 2001, Vice President and Deputy General Counsel; June 2001 to July 2003, Senior Vice President and Deputy General Counsel; July 2003 to date, Senior Vice President and General Counsel. September 1997 to July 2000, Associate General Counsel... View Full Profile

Lawrence V. Stein

Dr. Polan is 64 years old and has been a Director since 1995. She joined Stanford University School of Medicine in 1990 and is currently Professor and Chair Emeritus of the Department of Obstetrics and Gynecology. She is also a Director of Quidel Corporation.... View Full Profile

Dr. Mary Lake Polan, M.D., Ph.D., M.P.H.

Dr. Polan is 64 years old and has been a Director since 1995. She joined Stanford University School of Medicine in 1990 and is currently Professor and Chair Emeritus of the Department of Obstetrics and Gynecology. She is also a Director of Quidel Corporation.... View Full Profile

Robert Essner

Timothy P. Cost, 48, Senior Vice President, Corporate Affairs. Member of Management, Operations and Law/Regulatory Review Committees. Business Experience: 1996 to 2001, Vice President of Investor Relations and Corporate Intelligence for Bristol-Myers Squibb Company. 2001 to 2003, Senior Vice President of Corporate Affairs, Pharmacia Corporation. June 2003 to 2008, Executive Vice President, Corporate Affairs, ARAMARK Corporation, February 2008 to... View Full Profile

Timothy P. Cost

Richard R. DeLuca, Jr., 45, President, Fort Dodge Animal Health Division. Member of Management, Operations, Law/Regulatory Review and Human Resources and Benefits Committees. Business Experience: 1999 to 2001, Vice President - Finance, Wyeth Research, 2001 to 2002, Vice President - Global Finance, Wyeth Pharmaceuticals, 2002 to 2006, Senior Vice President of Finance and Administration/Chief Financial Officer, Fort Dodge Animal Health Division,... View Full Profile

Richard R. DeLuca, Jr.

Geno J. Germano, 47, President U.S., Pharmaceuticals and Women's Health Care. Member of Management and Operations Committees. Business Experience: 1999 to 2000, Vice President Marketing, Wyeth Pharmaceuticals, 2000 to 2002, Managing Director Australia/New Zealand, Wyeth Pharmaceuticals, 2002 to 2004, Executive Vice President and General Manager, Vaccines, Wyeth Pharmaceuticals, 2004 to 2007, Executive Vice President and General Manager, Pharma... View Full Profile

Geno J. Germano

Denise M. Peppard, 51, Senior Vice President - Human Resources. Member of Management, Operations, Law/Regulatory Review, Human Resources and Benefits and Retirement Committees. Business Experience: 1999 to 2000, Vice President Human Resources North America, Wyeth Pharmaceuticals, 2000 to 2001, Vice President Human Resources North America/Headquarters Operations, Wyeth Pharmaceuticals, 2007 to January 2008, Vice President - Corporate Human... View Full Profile

Denise M. Peppard

Cavan M. Redmond, 47, President, Wyeth Consumer Healthcare, Member of Management, Operations, Law/Regulatory Review and Human Resources and Benefits Committees. Business Experience: 2000 to 2001, Vice President, Deputy Chief Global Strategic Marketing, Wyeth Pharmaceuticals, 2001 to 2003, Senior Vice President Global Strategic Marketing, Wyeth Pharmaceuticals, 2003 to December 2007, Executive Vice President and General Manager BioPharma, Wyeth... View Full Profile

Cavan M. Redmond

On February 28, 2008, Wyeth announced the promotion of John C. Kelly to Vice President and Controller, Wyeth, effective March 28, 2008. Since joining Wyeth in 2002, Mr. Kelly has handled a wide range of assignments in finance, most recently as Vice President, Finance Operations. Prior to joining Wyeth, he was at Arthur Andersen LLP for more than 35 years where he served as a Partner in the firm, the Partner in Charge of the Audit & Business... View Full Profile

John C. Kelly, CPA

September 1995 to date, President, Fort Dodge Animal Health Division.... View Full Profile

E. Thomas Corcoran

Thomas Hofstaetter, Ph.D, 59, Senior Vice President - Corporate Business Development. Member of Management and Operations Committees. Business Experience: 1999 to September 2004, Senior Vice President, Corporate Development, Aventis, September 2004 to date, Senior Vice President, Corporate Business Development.... View Full Profile

Thomas Hofstaetter, Ph.D.

Charles A. Portwood, President - Technical Operations and Product Supply, Wyeth Pharmaceuticals. Member of Management, Operations and Law/Regulatory Review Committees. Business Experience: 1970 to November 2001, Senior Vice President, Strategy and Industrial Excellence, Aventis, November 2001 to July 2002, Senior Vice President, Global Supply Chain, Wyeth Pharmaceuticals, July 2002 to date, President - Technical Operations and Product Supply,... View Full Profile

Charles A. Portwood

April 2001 to June 2005, President, Wyeth Consumer Healthcare, U.S.; June 2005 to date, President, Wyeth Consumer Healthcare.... View Full Profile

Douglas A. Rogers

April 2001 to June 2005, President, Wyeth Consumer Healthcare, U.S.; June 2005 to date, President, Wyeth Consumer Healthcare.... View Full Profile

Kenneth J. Martin

Marily H. Rhudy, 60, Senior Vice President - Public Affairs. Member of Management, Operations and Law/Regulatory Review Committees. Business Experience: September 1997 to September 2004, Vice President - Public Affairs, September 2004 to date, Senior Vice President - Public Affairs.... View Full Profile

Marily H. Rhudy

Mary Katherine Wold, 55, Senior Vice President, Finance. Member of Human Resources and Benefits and Retirement Committees. Business Experience: 1988 to March 2002, Partner, Shearman & Sterling LLP, March 2002 to November 2005, Vice President - Taxes, November 2005 to June 2007, Senior Vice President - Taxes and Treasury, June 2007 to date, Senior Vice President - Finance.... View Full Profile

Mary Katherine Wold

June 1994 to September 2004, Vice President - Human Resources; September 2004 to date, Senior Vice President - Human Resources.... View Full Profile

Rene R. Lewin

Top Competitors: WYE

View Detailed Competitors Chart

Insider Trends: WYE
Sentiment for WYE is POSITIVE
- 0M
- 2M
- 4M
- 6M
- Market Value of Insider Sales
- Market Value of Insider Purchases
Total dollar value of all insider purchases and sales over 12 months
View All Insider Sentiment

Insider Transactions: WYE

Date	Name	Shares	Transaction Type	Market Value
05/06/08	WIINBERG ULF	66,528	Planned Sale	$3.03 M

Live Updates:

Ticker

Dynamic view of the market

WYETH

WYE

Stock price

Extended Hours

Analyst Consensus

WYETH Profile

Key Executives: WYE

Top Competitors: WYE

Insider Trends: WYE

Insider Transactions: WYE